BPC-157
Accelerates healing of tendons, ligaments, gut, and muscles throughout your body.
Read the full BPC-157 profileThe two most-discussed recovery peptides, head to head — how BPC-157 and TB-500 work, how they're dosed, and how people tend to use them together.
This page compares the same profile fields for both. It does not decide which is better, recommend either compound, or determine whether switching or combining them is appropriate.
Accelerates healing of tendons, ligaments, gut, and muscles throughout your body.
Read the full BPC-157 profilePromotes new blood vessel growth and reduces inflammation for stubborn injuries.
Read the full TB-500 profileBPC-157 is a stomach-derived peptide that signals tissue to heal faster, especially tendons, ligaments, nerves, and the gut lining, by boosting repair factors and protecting against inflammation and stress.
TB-500 (a thymosin beta-4 fragment) helps cells move, build new blood vessels, and calm inflammation so injured tissue (muscle, tendon, and wounds) can repair and regenerate more efficiently.
BPC-157 has been tested extensively in animals and is considered very safe. No lethal dose (LD50) has ever been established, even at amounts far beyond what anyone would use.
No long-term human studies exist.
Generally well tolerated. Use with caution in cancer history.
Avoid in active cancers without medical supervision. May promote cell growth.
250-500 mcg daily (once or twice)
daily
4-8 weeks on, then equal break
A typical 5mg vial = 10-20 days of use at 250-500 mcg/day
2-5 mg per week, split into 2 injections
twice_weekly
4-8 weeks on, 4 weeks off
Can load with 6 mg first week then reduce; inject subcutaneously
The rows above pull from the live peptide profile data used across The Peptide App. Use the comparison to spot differences in documented profile context, titration notes, and safety flags. Missing data remains missing rather than being inferred.
BPC-157 is summarized as: Accelerates healing of tendons, ligaments, gut, and muscles throughout your body. TB-500 is summarized as: Promotes new blood vessel growth and reduces inflammation for stubborn injuries.
Comparison questions are personal and context-dependent, so these answers stay educational instead of recommending a protocol.
BPC-157 and TB-500 are distinct compounds and can differ in mechanism, documented profile context, titration notes, evidence, and safety flags. The comparison table shows the same stored fields side by side and leaves unavailable information blank.
There is no universal answer, and this page does not rank or recommend either compound. A licensed professional can interpret the evidence, product status, and individual context; this page is only a structured research comparison.
Combining peptides can change dosing complexity and risk. This comparison is not medical advice, and it should not be used to start, stop, or combine protocols. A licensed professional is the right person to evaluate whether any combination is appropriate.
This comparison is for research and educational purposes. It does not diagnose, treat, prescribe, or replace guidance from a licensed professional. Always follow the instructions provided with your product.
Keep dose timing, reminders, and protocol notes in one place after you decide what you want to track.
Open either peptide profile, browse the peptide library, or compare another pair.